Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Immunovia AB (publ) · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2029 | $110.67M | $110.67M - $110.67M | -$110.67M | $0.00 | 1 |
| Dec 2028 | $55.33M | $55.33M - $55.33M | -$55.33M | -$0.02 | 1 |
| Dec 2027 | $17.10M | $17.10M - $17.10M | -$17.10M | -$0.04 | 1 |
| Dec 2026 | $3.02M | $3.02M - $3.02M | -$3.02M | -$0.101 | 1 |
| Dec 2025 | $997.5K | $997.5K - $997.5K | -$997.5K | -$0.539 | 1 |
| Dec 2024 | $619.28M | $619.28M - $619.28M | -$619.28M | $2.691 | 1 |
| Dec 2023 | $68.58M | $68.58M - $68.58M | -$68.58M | -$3.107 | 1 |
| Dec 2022 | $976.2K | $976.2K - $976.2K | -$976.2K | -$2.352 | 1 |
| Dec 2021 | $2.44M | $2.44M - $2.44M | -$2.44M | -$2.497 | 1 |
| Dec 2019 | $291.0K | $291.0K - $291.0K | -$291.0K | -$1.575 | 1 |
| Dec 2018 | $310.8K | $310.8K - $310.8K | -$310.8K | -$1.563 | 1 |
| Dec 2017 | $28.41M | $28.41M - $28.41M | -$28.41M | -$0.381 | 1 |